NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
This Quarter Return
+4.17%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$1.5B
AUM Growth
+$1.5B
(-3.2%)
Cap. Flow
-$64.2M
Cap. Flow
% of AUM
-4.28%
Top 10 Holdings %
Top 10 Hldgs %
32.63%
Holding
124
New
18
Increased
34
Reduced
22
Closed
15
Top Buys
| 1 |
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
|
$34.7M |
| 2 |
FirstCash
FCFS
|
$24.7M |
| 3 |
TFFP
TFF Pharmaceuticals, Inc. Common Stock
TFFP
|
$21.7M |
| 4 |
Syndax Pharmaceuticals
SNDX
|
$19.8M |
| 5 |
TA
TravelCenters of America LLC
TA
|
$18.8M |
Top Sells
| 1 |
RH
RH
|
$39.3M |
| 2 |
Medifast
MED
|
$37.9M |
| 3 |
Tenet Healthcare
THC
|
$35.9M |
| 4 |
HCA Healthcare
HCA
|
$30.6M |
| 5 |
Adicet Bio
ACET
|
$29.6M |
Sector Composition
| 1 | Healthcare | 39.1% |
| 2 | Consumer Discretionary | 13.23% |
| 3 | Industrials | 10.41% |
| 4 | Technology | 9.82% |
| 5 | Financials | 8.38% |
